Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Urinary markers in the surveillance setting of non-muscle invasive bladder cancer

Dr Thomas Dreyer - Aarhus University Hospital, Aarhus, Denmark
Urinary markers in the surveillance setting of non-muscle invasive bladder cancer ( Dr Thomas Dreyer - Aarhus University Hospital, Aarhus, Denmark )
10 Apr 2024

Chemo-immunotherapy combo nivolumab and nab-paclitaxel could be effective perioperative strategy for MIBC

Dr Chiara Mercinelli - San Raffaele Scientific Institute, Milan, Italy
Chemo-immunotherapy combo nivolumab and nab-paclitaxel could be effective perioperative strategy for MIBC ( Dr Chiara Mercinelli - San Raffaele Scientific Institute, Milan, Italy )
10 Apr 2024

EAU 2024: Bladder cancer latest

Dr Bernadett Szabados, Dr Félix Guerrero-Ramos, Dr Yohann Loriot, Prof Andrea Necchi and Dr Cosimo De Nunzio
EAU 2024: Bladder cancer latest ( Dr Bernadett Szabados, Dr Félix Guerrero-Ramos, Dr Yohann Loriot, Prof Andrea Necchi and Dr Cosimo De Nunzio )
9 Apr 2024

Concurrent low-dose radiation and durvalumab and etoposide/platinum shows promising efficacy in 1L ES-SCLC

Dr Yan Zhang - Sichuan University, Chengdu, China
Concurrent low-dose radiation and durvalumab and etoposide/platinum shows promising efficacy in 1L ES-SCLC ( Dr Yan Zhang - Sichuan University, Chengdu, China )
6 Apr 2024

Pembrolizumab improves breast cancer outcomes regardless of age or menopausal status

Dr Javier Cortes - International Breast Cancer Center, Barcelona, Spain
Pembrolizumab improves breast cancer outcomes regardless of age or menopausal status ( Dr Javier Cortes - International Breast Cancer Center, Barcelona, Spain )
26 Mar 2024

Exercise positively effects symptom burden and quality of life of metastatic breast cancer patients

Dr Anouk Hiensch - UMC Utrecht, Utrecht, Netherlands
Exercise positively effects symptom burden and quality of life of metastatic breast cancer patients ( Dr Anouk Hiensch - UMC Utrecht, Utrecht, Netherlands )
25 Mar 2024

Using AI to identify patients at increased risk of side effects from radiation treatment for breast cancer

Dr Tim Rattay - University of Leicester Cancer Research Centre, Leicester, UK
Using AI to identify patients at increased risk of side effects from radiation treatment for breast cancer ( Dr Tim Rattay - University of Leicester Cancer Research Centre, Leicester, UK )
25 Mar 2024

Twice-daily chemoradiation remains the standard of care in limited stage small-cell lung cancer

Dr Gerard Walls - Queen's University Belfast, Belfast, Northern Ireland
Twice-daily chemoradiation remains the standard of care in limited stage small-cell lung cancer ( Dr Gerard Walls - Queen's University Belfast, Belfast, Northern Ireland )
25 Mar 2024

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus

Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale Tomasini
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus ( Dr Anna Minchom, Prof Enriqueta Felip, Prof Nicolas Girard and Prof Pascale Tomasini )
25 Mar 2024

Treatment of multiple myeloma in Singapore and Asia

Prof Wee Joo Chng - National University of Singapore, Singapore
Treatment of multiple myeloma in Singapore and Asia ( Prof Wee Joo Chng - National University of Singapore, Singapore )
13 Mar 2024

Optimising multiple myeloma care in Latin America

Dr David Gómez-Almaguer - Autonomous University of Nuevo León, Monterrey, Mexico
Optimising multiple myeloma care in Latin America ( Dr David Gómez-Almaguer - Autonomous University of Nuevo León, Monterrey, Mexico )
6 Mar 2024

Special Issue on paediatric oncology

Prof Tezer Kutluk - Hacettepe University Faculty of Medicine & Cancer Institute, Sıhhiye-Ankara, Turkey
Special Issue on paediatric oncology ( Prof Tezer Kutluk - Hacettepe University Faculty of Medicine & Cancer Institute, Sıhhiye-Ankara, Turkey )
28 Feb 2024